Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial

Author:

Chen Hong-Hwa1,Lin Jen-Kou2,Chen Joe-Bin3,Chuang Chieh-Han4,Liu Mei-Ching5,Wang Jen-Yi6,Changchien Chung-Rong7

Affiliation:

1. Chang Gung Memorial Hospital; Kaohsiung Taiwan

2. Taipei Veterans General Hospital; Taipei Taiwan

3. Taichung Veterans General Hospital; Taichung Taiwan

4. Kaohsiung Medical University Hospital; Kaohsiung Taiwan

5. Koo Foundation Sun Yat-Sen Cancer Center; Taipei Taiwan

6. Chang Gung Memorial Hospital; Chai-Yi Taiwan

7. Linkou Chang Gung Memorial Hospital; Linkou Taiwan

Funder

F. Hoffmann-La Roche

Publisher

Wiley

Subject

Oncology,General Medicine

Reference48 articles.

1. Global estimates of cancer prevalence for 27 sites in the adult population in 2008;Bray;Int J Cancer,2013

2. Ferlay J Soerjomataram I Ervik M GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 http://globocan.iarc.fr

3. Management of potentially resectable colorectal cancer liver metastases;Meriggi;World J Gastrointest Surg,2013

4. Neoadjuvant chemotherapy for metastatic colorectal cancer to the liver: From chemotherapy to targeting therapy;Teng;Hepatobiliary Pancreat Dis Int,2008

5. Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases;Barone;Br J Cancer,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3